chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was feeling flu-like on 6/27 and very tired. I had a minor sore throat and cough on 6/28. On the morning of 6/29 I did a rapid home test and it showed a strong positive result. I called the doctor and had a virtual telephonic visit. She said I was eligible for Paxlovid and she prescribed dosage: Paxlovid Tablets (Renal Lower Dose). I took 2 tablets by mouth (1 pink and 1 white) at the same time twice daily. I was feeling uncomfortable and tired on 6/29 and 6/30 and drank lots of water and got up on the morning of 6/31 and went for a 2 mile walk and felt great! I have felt fine since then so this was probably breakthrough case of Covid.
Chills, joint ache, nausea, and fever.  Temperature was at 101°F before taking 975 mg Tylenol at 10 PM. Fever peaked at 101.7°F at 11 PM then was kept at 101°F until it broke at 4 AM.  Additional Tylenol at 4 AM and 400 mg ibuprofen at 9 AM. Feeling of weakness persisted until morning of 11/14.
shot spot had a mild reddish reaction and it became itchy from day-3 and lasted about a week. At the same time, I also had a dull headache, it's also gone now.  On day-4, I started to have a very mild, spotty itchy rash around the front of my waist, it lasted about 12 days, when it became too itchy, I applied a thin coat of Triamcinolone acetonide 0.1% on the spots, it seemed to work for about a day or two, I had used it about 4 times.
No symptoms on first dose, except left arm softness that night.  Five minutes after second dose, I felt dizziness, cold sweat,  leg numbness, cold finger tips and an increased heat rate.
7pm 01/02/2021- Right hand became itchy: urticaria appeared across right hand, left wrist, elbow creases, right foot. 1pm 01/03/2021- went for a run while wearing a sterling silver necklace (which has been worn almost every day for past year) began to feel a burning sensation. Took off necklace and had urticaria all around neck where necklace had been.  (took ice baths, used lotion, and took 2 tablets of hydroxyzine which all alleviated itchiness and most of the redness/bumps had disappeared when waking up on 01/04/2021).
PAIN IN RIGHT ARM AT INJECTION SITE TO SHOULDER BLADE, HAND DOWN TO FINGERS, AND PAINFUL TO BONE; NUMB ARM; This spontaneous report received from a patient concerned a 39 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: 19-SEP-2021) dose was not reported, administered on 22-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-MAY-2021, the patient experienced pain in right arm at injection site to shoulder blade, hand down to fingers, and painful to bone. On 22-MAY-2021, the patient experienced numb arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in right arm at injection site to shoulder blade, hand down to fingers, and painful to bone, and the outcome of numb arm was not reported. This report was non-serious.
extreme fatigue,  mod headache and arm/ hand weakness that became worse as days went on.  to point I couldn't use my hands - severe weakness on various fingers (comes and goes) or lift my arms above my shoulders
He received his second dose of Pfizer vaccine on 7/30, around noon and soon after developed a headache (more on left side) and an elevated temperature of 100F. Family was more attentive to symptoms following 2nd vaccine, given that after is first dose roughly 2 weeks ago, he developed a widespread rash on his face requiring IM Benadryl and steroids to control. Yesterday, he was very weak unable to assist with normal household chores and later he woke early this AM with 9/10 chest pain over parasternal region, radiating to his neck and left shoulder. Pain was stabbing, wax/waning, and lasted 20 minutes with associated SOB and palpitations. HR ranged from 60-120bpm per wrist monitor. Episode resolved when  flat. A second identical episode reoccurred roughly 4 hours later but was self resolved. He subsequently took one tablet of Chlortab antihistamine and Alka-Seltzer with minor relief in symptoms. Out of concern, family presented to ED for further workup. Family history pertinent for father with history of A. fib and myocarditis with COVID infection in October 2020.    Presented to the ED, 3 days s/p second Pfizer dose with sudden onset parasternal chest pain, palpitations, and shortness of breath with laboratory evaluation consistent with myocarditis.  Patient has a history of prior skin reaction following first dose of vaccine which subsequently required IM antihistamine oral steroids to alleviate.  Current symptoms developed within hours of second dose, beginning with headache and elevated temperatures, later transitioning to weakness, chest pain, and shortness of breath last night.  Pain described as parasternally radiating at times to neck and left shoulder and is not reproducible on exam.    Further cardiac history of MI related death in paternal grandfather in his 40s and additional multiple MIs in maternal grandfather in 50s.
Headache, Myalgia, Diarrhea, left arm sore, achey, chills Narrative:
This spontaneous report was received from a physician via a company representative, referring to a 82 year old female patient. The patient's medical history and concurrent conditions were not reported. On an unknown date (reported as "a few years ago"), the patient was vaccinated with a ZOSTAVAX (dose, frequency, route, lot # and expiration date were not reported). No concomitant medications were reported. On an unknown date (reported as recently), the patient presented with a case of shingles. At the time of the report, the outcome of shingles was unknown. No product quality complaint was involved. Additional information is not expected as no further information can be obtained from the physician.
Pain down Rt leg explained as a deep muscle pain, started approx 4 PM 2-2-16,  Pain down Left side of torso started approx 9 PM 2-2-16, Burning and Frequent urination started in the AM on 2-3-16, Reddened area at sight of injection 2-3-16.  Client reports that the frequent urination and pain in the left torso ended by 2-6-16, but the pain in the Rt leg continued until 2-16-16.  Client reports that the redness at the sight of injection is still present but is very faint.  Client reports that she took Advil as needed for the discomfort.
Sore arm with a small pus filled bump. I applied alcohol on it after popping it, then a bandaid. It went away the following day. My neck for two days on and off stiffened and tightened on my right side. I took two 325mg aspirin. It lasted two days. I developed a cough, sneezing, runny nose, congestion,and mild sweat(currently on day five.)
Immediately after injection significant arm pain that resolved quickly. Approximately 36 hours after injection dizziness. 48 hours after injection neck and head pain on left side, arm soreness, and swollen lymph node on left side of throat. Minor pain in mouth and throat with fatigue and dizziness. Neck and head pain decreasing on day 3 with all other effects resolving but injection site is still fairly sore. Overall, I would say this was probably a normal response associated with my immune system reacting to the injection. I had the virus the first week of December 2020. I would classify my infection as moderate. I was sick with fever, chills and severe body aches and it lasted for 10-14 days.
6 days after vaccine in the right arm a large, puffy "mass" like developed under my arm, in arm pit. Large lump, tender to touch and when moving arm. Feels muscular to me and/or lymph node related? After 4 days (today), less swollen, less painful but still visible and tender.
Seizures; she could walk the 2nd night; she has been out of school all week; This case was reported by a consumer via interactive digital media and described the occurrence of seizure in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced seizure (serious criteria GSK medically significant), mobility decreased and activities of daily living impaired. On an unknown date, the outcome of the seizure, mobility decreased and activities of daily living impaired were unknown.   It was unknown if the reporter considered the seizure, mobility decreased and activities of daily living impaired to be related to Meningococcal B vaccine.  Additional case details were reported as follows: The reporter was patient's parent. The age at vaccination was not reported. The patient was out of school all week because of vaccination and she could walk the 2nd night and her medications were not keeping her from having seizures. The follow up was not required.
Soreness and swelling began late in the evening which was expected. Began chills for several hours during the night. Early morning had a low grade temp of 100.2. On the next day about noon my arm felt on fire and I noted that some blistering such as seen with shingles had appeared on the medial aspect of the injection in my left upper deltoid. It was approximately 1/2 inch area involved. I did call pharmacy later in the day to see if this was a normal reaction and was told by the pharmacist that he had never heard of that problem before.  It took about 3 days for the blisters to decrease and then disappear. No further treatment was necessary.
Patient was ineligible to receive her first dose Moderna vaccination due to age requirements of the vaccine - patient was 17 at the time of vaccination.
"CHIEF COMPLAINT:arm and hand pain      HISTORY OF PRESENT ILLNESS:  had hand and shoulder and arm pain after 1st CVOI vaccine and went away. sx  mild.  but after 2nd dose significnat disomcomfrt.  sometimes wakes him h up at  night all joits flared up after vaccine but really noticable and continues since  then ASSESSMENT AND PLAN:  1) cervical radiculoapthy-- likely c-spine djd exacerbatied by COVID-19  vaccination.  Recommend x-rays and PT.  Canconsider gabapentin if sx worsen in  future.   2) Bilateral hand pain in multiple joints- likely OA of hands aggravated by  COVID-19 vaccine-- contiune prn iburpofen by outsdie PCP.  d/c diclofenac gel.  pt educate on the risks of concurrent use of both"
Patient reported hives/rash about 30 minutes after administration of the immunization. We referred patient to urgent care where an injectable steroid was administered which resolved the reaction. No further action was necessary per patient.
Noticed swelling Tues 5/22.  Received shot 5/17. Pain extends down to elbow and up toward back shoulder and neck area.  Aches feel like flu aches.  Swelling is in muscle and it looks like I have a bigger muscle.
Mom called clinic 9/29/2015 to report on 9/28/2015 patient started having generalized hives all over and slight wheezing. Advised mom to take to PCP or ER.
p/vax pt exp h/a & flu like sx a few hr p/vax;
DTaP #4 was administered on 3/16/17 on left thigh. Vaccine was expired on 3/5/17 (11 days prior to administration) local swelling reported by parent.
Experienced numbness and tingling unilaterally to one side of face. Began 45 minutes after vaccination and lasted 4 hours.
Fever, chills, whole body ache, nausea, headache. Symptoms lasted about 24 hours, controlled with over the counter NSAIDs.
Approximately 25mg swollen area at site of injection = approx 3/4 of upper arm around site red.
past 42 days for second dose, has yet to receive 2nd dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (past 42 days for second dose, has yet to receive 2nd dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (past 42 days for second dose, has yet to receive 2nd dose). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (past 42 days for second dose, has yet to receive 2nd dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: FU received on 24-May-21. Both dose batch number mentioned. Second dose details provided.
Arm very sore, very red about 4 inches wide from injection area to all around my arm. That night had aches + pains like flu, sore throat, headache, pain in back of my head. was sick all weekend. Felt like worst case of flu ever.
Patient called Pharmacy STORE 1842 on 8/12/22 @  6:30pm. to report chills, sneezing, cough and body aches ONE DAY after receiving her MODERNA BOOSTER vaccine (administered on 8/11/22). The symptoms started at 2pm on 8/12/22 and continued and she took a Tylenol tablet OTC to reduce her symptoms
This patient had extreme redness, swelling, heat and pain at the injection site. She also had a fever of 103 F, weakness, chills, , dizziness, nausea, / disorientation. The patient desires to report events so manufacturer will be aware.
Pt recvd 3 doses of Hep B vax 10MAR87; 9APR87, 10SEP87; titer was checked APR88 & it was determined that anti-Hep B surface was reactive; then titer was checked JUN90 & it was determined that anti Hep B was non reactive;
his left arm feels dead; This is a spontaneous report based on information received by Pfizer. A 63-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, Patient reported he had the Covid-19 vaccine few weeks after he noticed that his left arm feels dead. The outcome of the event was unknown.   No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
The day after receiving the Shingles vaccine I felt aches in my forehead and back of my neck at the occiput, mild dizziness, tinnitus and pains in my joints. I have these joint pains and dizziness fairly often but this time they were more bothersome and accompanied by the headaches and some weakness. Also, these conditions persisted - from about 2:00 a.m. the next day through the afternoon.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65-month-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Mar2021 as dose 1, single (Lot number: EP6955), in right arm and on 29May2021 as dose 2, single (Lot number: EW0164) at the age of 64 years, in right arm for covid-19 immunisation; coviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 22Nov2021 as dose 3 (booster), single (Lot number: 012H21B), in right arm for Covid-19 immunisation. The patient's relevant medical history included: "Dose 3 Moderna/ Dose 1 and Dose 2 Pfizer" (unspecified if ongoing), notes: Dose 3 Moderna/ Dose 1 and Dose 2 Pfizer. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 03May2022, outcome "unknown", COVID-19 (medically significant) with onset 03May2022, outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03May2022) Positive; (08May2022) Negative; (18May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, Covid-19. No allergies reported.
Slight temperature 99F and cramps in the abdomen, diarrhea, muscle aches and malaise lasting over a week. I was taken to local ER and after ER physician evaluation and lab work I was given IV fluid to make up Na and K deficit and to rectify the dehydration. The ER visit was on September 1st, 2014 afternoon.
This case was reported by a other health professional via call center representative and described the occurrence of injection site joint warmth in a 50-year-old female patient who received FLUARIX QUADRIVALENT (batch number unknown, expiry date June 2015) and (batch number AS457), expiry date June 2015). Previously experienced adverse reactions included similar reaction on previous exposure to drug. On 24th September 2014 07:30, the patient received FLURARIX (intramuscular). On an unknown date, the dose was an unknown dose. On 24th September 2014 20:00, 12 hrs 30 min after receiving FLUARIX, the patient experienced injection site joint warmth and injection site joint swelling. On an unknown date, the outcome of the injection site joint warmth and injection site joint swelling were recovering/resolving. The reporter considered the injection site joint warmth and injection site joint swelling to be unrelated to FLUARIX. Additional information received: Patient received .5 ml of FLUARIX QUADRIVALENT vaccine at 7:30 in the morning on the 24th of September. At 8 pm on that same day patient noticed that the collar bone was warm and collar bone was a little swollen. Patient did not have any fever. Patient only spoke to a nurse at the school where she works. Patient did not receive any other vaccines on that day. Reporter does not know if patient is taking other medications. Reporter does not believe that the event is related to FLUARIX; however, the patient does. Following GSK internal checks on lot number, on 11 May 2015 the reported suspect vaccine FLUARIX has been corrected and replaced by FLUARIX QUADRIVALENT. Case Comment: Patient received a .5 ml of FLUARIX QUADRIVALENT vaccine at 7:30 in the morning on the 24th of September. At 8 pm on that same day patient noticed that the collar bone was warm and collar bone was a little swollen. Patient did not have any fever. Patient only spoke to a nurse at the school where she works. Patient did not receive any other vaccines on that day. Reporter does not know if patient is taking other medications. Reporter does not believe that the event is related to FLUARIX; however, the patient does.
2 year old received a Boostrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43JH7, expiry date 23rd November 2023) for prophylaxis.   On 22nd February 2022, the patient received Boostrix. On 22nd February 2022, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK Receipt Date: 04-APR-2022 Reporter's Comments: The 2 years old patient received a Boostrix dose, which led to Inappropriate age at vaccine administration. The reporter consented to follow-up.
High fever 104.1 (2 days after 12) several days, she complained of her right ear hurting, saw physician 09/08.  Saw doctor "said symptoms likely due to immunizations", treat fever with Tylenol, give her a couple days.  Symptoms became worse, high fever, vomiting, saw physician, treated ear infection with antibiotics.  Since, her hair has been falling out, her hearing seems to be effected by how well she hears things sharply.
Immediately after receiving vaccine, patient reports that he had numbness from his elbow into his last 2 digits of his had on left arm (arm the injection was placed in deltoid). Within an hour of receiving the vaccine, he developed rhinorrhea and bilateral itching of his eyes as well as increased pain at injection site (left deltoid). By that evening he developed a severe headache, generalized body aches, and excessive fatigue.  These symptoms continued through the next couple of days to the point he almost had to miss work. One week later (12/30) he has now developed a rash down his entire left arm into his hand that is red, blotchy, and itchy. He has improvement in headache, body aches, and fatigue now (12/31/20).
RIGHT ARM SORENESS; This spontaneous report received from a patient concerned a 69 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included type 1 diabetes, and heart disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 24-MAR-2021 to Right Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 24-MAR-2021, the patient experienced right arm soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from right arm soreness. This report was non-serious.
vertigo; dizziness; fatigue; chills; headache; elevated temperature (around 100F); light nausea; achiness; muscle and joint aches; muscle and joint aches; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Feb2021 13:00 (Batch/Lot Number: EL3247) at the age of 38 years, as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. He was not diagnosed with COVID-19 prior to vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), in left arm on 27Jan2021 (Batch/Lot Number: EL3247) at the age of 38 years, as dose 1, single for COVID-19 immunization and experienced mild pain at the side of vaccination (left arm). On 17Feb2021 21:00, about 8h after the vaccination, the patient experienced chills, headache, elevated temperature (around 100F), light nausea, achiness/ muscle and joint aches, and fatigue. The patient was informed about the possibility of these common side effect by the person who administered the vaccine. The symptoms ceased about 48h after. In addition, the patient started experiencing nausea and vertigo/ dizziness on 22Feb2021, 4th day after the vaccination. The patient did not think that they were related to the vaccine but still wanted to report them. He reported that he cleaned his ear with a q-tip on 21Feb2021 which might have caused the symptoms. The patient did not receive treatment for the events. Outcome of chills, headache, elevated temperature (around 100F), light nausea, achiness/ muscle and joint aches, and fatigue was recovered on 19Feb2021 21:00; of remaining events was unknown. Patient was not tested for COVID-19 post-vaccination.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on known drug safety profile and temporal relationship there is reasonable possibility of causal association between the reported events vertigo, dizziness and the suspect drug BNT162B2.